Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 26 11453-11453 2023年
Purpose: Coronavirus disease 2019 (COVID-19) mRNA vaccines are used worldwide to prevent severe symptoms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. IgA nephropathy (IgAN) is the most common form of glomerular injury...
Takahiro Kato   Tomohiro Mizuno   Masanori Nakanishi   Jeannie K Lee   Shigeki Yamada   Naotake Tsuboi   Kazuo Takahashi   
In vivo (Athens, Greece) 37(3) 1236-1245 2023年
BACKGROUND/AIM: Sepsis is a life-threatening biological condition that induces systemic tissue and organ dysfunction and confers a high mortality risk. Although the use of hydrocortisone in combination with ascorbic acid and thiamine (HAT therapy)...
A long-term high-fat diet (HFD) causes obesity and changes in renal lipid metabolism and lysosomal dysfunction in mice, causing renal damage. Sodium-glucose co-transporter inhibitors, including phlorizin, exert nephroprotective effects in patients...
Galactose (Gal)-deficient IgA1 (Gd-IgA1) is involved in IgA nephropathy (IgAN) pathogenesis. To reflect racial differences in clinical characteristics, we assessed disease- and race-specific heterogeneity in the O-glycosylation of the IgA1 hinge r...
国際IgAシンポジウムにて研究成果を評価され受賞、その内容を大学院生の研究指導にフィードバックした。[Jean Berger Prize]Kazuo Takahashi, Hitoshi Suzuki, Koshi Yamada, Stacy Hall, Zina Moldoveanu, Knud Poulsen, Mogens Kilian, Jiri Mestecky, Bruce A. Julian, Matthew B. Renfrow, Jan Novak. Molecular Characterization of IgA1 Secreted by IgA1-producing Cell Lines from Patients with IgA Nephropathy. 13th International Symposium on IgA Nephropathy; 4-6th June, 2013, Nanjing, China